Sjögren's syndrome (SS) is a systemic autoimmune disease that frequently occurs concomitantly with other systemic connective tissue disorders, including rare and complex diseases such as systemic lupus erythematosus (SLE) and systemic sclerosis (SSc). The presence of SS influences the clinical expression of the other autoimmune diseases, thus offering the unique opportunity to explore the similarities in genetic signatures, as well as common environmental and biologic factors modulating the expression of disease phenotypes. In this review, we will specifically discuss the possibility of defining "SS/SLE" and "SS/SSc" as distinct subsets within the context of connective tissue diseases with different clinical expression and outcomes, thus deserving an individualised assessment and personalised medical interventions.
Sjögren's syndrome and other rare and complex connective tissue diseases: an intriguing liaison / C. Baldini, L. Arnaud, T. Avčin, L. Beretta, C. Bellocchi, C. Bouillot, G. Burmester, L. Cavagna, M. Cutolo, J.K. de Vries-Bouwstra, A. Doria, F. Ferro, J.E. Fonseca, S. Fonzetti, G. Fulvio, I. Galetti, J. Gottenberg, E. Hachulla, T. Krieg, G. La Rocca, T. Martin, M. Matucci-Cerinic, P. Moinzadeh, C. Montecucco, M. Mosca, L. Mouthon, U. Müller-Ladner, S. Rednic, V. Smith, R. Talarico, J.M. van Laar, A. Vieira, V.C. Romão, X. Mariette. - In: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. - ISSN 1593-098X. - 40:5(2022 May 18), pp. S103-S112. [10.55563/clinexprheumatol/3y0hqs]
Sjögren's syndrome and other rare and complex connective tissue diseases: an intriguing liaison
C. Bellocchi;
2022
Abstract
Sjögren's syndrome (SS) is a systemic autoimmune disease that frequently occurs concomitantly with other systemic connective tissue disorders, including rare and complex diseases such as systemic lupus erythematosus (SLE) and systemic sclerosis (SSc). The presence of SS influences the clinical expression of the other autoimmune diseases, thus offering the unique opportunity to explore the similarities in genetic signatures, as well as common environmental and biologic factors modulating the expression of disease phenotypes. In this review, we will specifically discuss the possibility of defining "SS/SLE" and "SS/SSc" as distinct subsets within the context of connective tissue diseases with different clinical expression and outcomes, thus deserving an individualised assessment and personalised medical interventions.File | Dimensione | Formato | |
---|---|---|---|
article.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
421.5 kB
Formato
Adobe PDF
|
421.5 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.